Adverse Events
Adverse events should be reported. Reporting forms and information can be found at www.hpra.ie/homepage/about-us/report-an-issue.
Adverse events should also be reported to Boehringer Ingelheim Drug Safety on 1850 946100.
For Republic of Ireland healthcare
professionals only
For treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE),
and prevention of recurrent DVT and PE in adults1,2
Treatment and secondary prevention of DVT and PE
Treatment and secondary prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE)
Adverse events should be reported. Reporting forms and information can be found at www.hpra.ie/homepage/about-us/report-an-issue.
Adverse events should also be reported to Boehringer Ingelheim Drug Safety on 1850 946100.
References: